Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.
McIntosh CH, Demuth HU, Kim SJ, Pospisilik JA, Pederson RA. McIntosh CH, et al. Int J Biochem Cell Biol. 2006;38(5-6):860-72. doi: 10.1016/j.biocel.2005.12.013. Epub 2006 Jan 11. Int J Biochem Cell Biol. 2006. PMID: 16442340 Review.
Pancreatic β-cell prosurvival effects of the incretin hormones involve post-translational modification of Kv2.1 delayed rectifier channels.
Kim SJ, Widenmaier SB, Choi WS, Nian C, Ao Z, Warnock G, McIntosh CH. Kim SJ, et al. Among authors: mcintosh ch. Cell Death Differ. 2012 Feb;19(2):333-44. doi: 10.1038/cdd.2011.102. Epub 2011 Aug 5. Cell Death Differ. 2012. PMID: 21818121 Free PMC article.
Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats.
Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhouse W, Finegood DT, McIntosh CH, Pederson RA. Pospisilik JA, et al. Among authors: mcintosh ch. Diabetes. 2002 Apr;51(4):943-50. doi: 10.2337/diabetes.51.4.943. Diabetes. 2002. PMID: 11916911
Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY.
Unniappan S, McIntosh CH, Demuth HU, Heiser U, Wolf R, Kieffer TJ. Unniappan S, et al. Among authors: mcintosh ch. Diabetologia. 2006 Aug;49(8):1915-23. doi: 10.1007/s00125-006-0310-8. Epub 2006 Jun 27. Diabetologia. 2006. PMID: 16802131
Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.
Demuth HU, McIntosh CH, Pederson RA. Demuth HU, et al. Among authors: mcintosh ch. Biochim Biophys Acta. 2005 Aug 1;1751(1):33-44. doi: 10.1016/j.bbapap.2005.05.010. Biochim Biophys Acta. 2005. PMID: 15978877 Review.
Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.
Pospisilik JA, Stafford SG, Demuth HU, McIntosh CH, Pederson RA. Pospisilik JA, et al. Among authors: mcintosh ch. Diabetes. 2002 Sep;51(9):2677-83. doi: 10.2337/diabetes.51.9.2677. Diabetes. 2002. PMID: 12196458
Rebuttal to Deacon and Holst: "Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1" versus "Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective".
Demuth HU, Hinke SA, Pederson RA, McIntosh CH. Demuth HU, et al. Among authors: mcintosh ch. Biochem Biophys Res Commun. 2002 Aug 16;296(2):229-32. doi: 10.1016/s0006-291x(02)00753-2. Biochem Biophys Res Commun. 2002. PMID: 12163006 No abstract available.
On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors.
Hinke SA, McIntosh CH, Hoffmann T, Kühn-Wache K, Wagner L, Bär J, Manhart S, Wermann M, Pederson RA, Demuth HU. Hinke SA, et al. Among authors: mcintosh ch. Diabetes Care. 2002 Aug;25(8):1490-1; author reply 1491-2. doi: 10.2337/diacare.25.8.1490-b. Diabetes Care. 2002. PMID: 12145269 No abstract available.
Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM).
Hinke SA, Pederson RA, McIntosh CH. Hinke SA, et al. Among authors: mcintosh ch. Adv Exp Med Biol. 2006;575:119-33. doi: 10.1007/0-387-32824-6_13. Adv Exp Med Biol. 2006. PMID: 16700515 Review. No abstract available.
Dipeptidyl peptidase IV inhibitors and diabetes therapy.
McIntosh CH. McIntosh CH. Front Biosci. 2008 Jan 1;13:1753-73. doi: 10.2741/2797. Front Biosci. 2008. PMID: 17981665 Review.
136 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback